BLTE
Belite Bio Inc ADR
NASDAQ: BLTE · HEALTHCARE · BIOTECHNOLOGY
$152.44
-2.25% today
Updated 2026-07-29
Market cap
$6.15B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.53
Dividend yield
—
52W range
$60 – $200
Volume
0.2M
WallStSmart proprietary scores
20
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C7.3
Quality
B+3.0
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
46.0
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$210.50
+38.09%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
2 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 45.99 — safe zone
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-12.65M | $-31.63M | $-36.14M | $-77.61M | $-26.94M |
| EPS | — | — | — | — | $-2.53 |
| Free cash flow | $-11.85M | $-29.90M | $-29.39M | $-37.17M | — |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Belite Bio Inc ADR trades at $152.44. Our Smart Value Score of 20/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 45.99, it sits in the safe zone.
Frequently asked questions
What is Belite Bio Inc ADR's stock price?
Belite Bio Inc ADR (BLTE) trades at $152.44.
Is Belite Bio Inc ADR overvalued?
Belite Bio Inc ADR carries a Smart Value Score of 20/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Belite Bio Inc ADR (BLTE)?
The 12-month analyst consensus target is $210.50, about 38.1% above the current $152.44. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Belite Bio Inc ADR's Altman Z-Score is 45.99, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-11.34%
Beta-1.23
50D MA$146.62
200D MA$146.07
Shares out0.04B
Float0.02B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—